Ligand Pharmaceuticals
LGNDLigand Pharmaceuticals is a biopharmaceutical royalty company that specializes in acquiring and managing diversified royalty streams from high-value medicines.
Earnings
Next report
Date not yet announcedFinancials
Q3 2026Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
Ligand Pharmaceuticals is a biopharmaceutical royalty company that specializes in acquiring and managing diversified royalty streams from high-value medicines. The company deploys capital through royalty purchases, development-stage financing, and strategic acquisitions of assets with embedded royalty rights. Its business model focuses on generating long-duration, non-dilutive cash flows with a lean corporate infrastructure by leveraging the R&D and commercial capabilities of its partners.
Ligand occupies a niche as a high-margin royalty aggregator with significant operating expertise, differentiating itself from traditional biotech firms by avoiding high-cost R&D infrastructure.
FAQ
- What is Ligand Pharmaceuticals's market cap?
- Ligand Pharmaceuticals (LGND) has a market capitalization of $6.3B and trades on NASDAQ.
- What is Ligand Pharmaceuticals's revenue and profitability?
- Ligand Pharmaceuticals generated $253.8M in trailing twelve-month revenue with net income of $51.5M, representing a net margin of 20.3%. Gross margin stands at 91.9%. The latest reported period is Q3 2026.
- Who are Ligand Pharmaceuticals's competitors?
- Ligand Pharmaceuticals's key competitors include Royalty Pharma, CNS Pharmaceuticals, Inc. Common Stock, Roivant Sciences Ltd. Common Shares, and others. These companies compete in similar markets and product categories.
- Who does Ligand Pharmaceuticals partner with?
- Ligand Pharmaceuticals's notable partners include Amgen, Merck, Travere Therapeutics, and others.
- What subsidiaries does Ligand Pharmaceuticals have?
- Ligand Pharmaceuticals's subsidiaries include CyDex Pharmaceuticals, Ligand UK Development Limited, Pelthos Therapeutics, and others.
- Where is Ligand Pharmaceuticals headquartered?
- Ligand Pharmaceuticals is headquartered in United States of America and employs approximately 58 people. It has been publicly traded since 1994.
